» Articles » PMID: 35044691

Causal Inference Methods for Vaccine Sieve Analysis with Effect Modification

Overview
Journal Stat Med
Publisher Wiley
Specialty Public Health
Date 2022 Jan 19
PMID 35044691
Authors
Affiliations
Soon will be listed here.
Abstract

The protective effects of vaccines may vary depending on individual characteristics, such as age. Traditionally, such effect modification has been examined with subgroup analyses or inclusion of cross-product terms in regression frameworks. However, in many vaccine settings, effect modification may also depend on the infecting pathogen's characteristics, which are measured postrandomization. Sieve analysis examines whether such effects are present by combining pathogen genetic sequence information with individual-level data and can generate new hypotheses on the pathways whereby vaccines provide protection. In this article, we develop a causal framework for evaluating effect modification in the context of sieve analysis. Our approach can be used to assess the magnitude of sieve effects and, in particular, whether these effects are modified by individual-level characteristics. Our method accounts for difficulties occurring in real-world data analysis, such as competing risks, nonrandomized treatments, and differential dropout. Our approach also integrates modern machine learning techniques. We demonstrate the validity and efficiency of our approach in simulation studies and apply the methodology to a malaria vaccine study.

References
1.
Agnandji S, Lell B, Fernandes J, Abossolo B, Methogo B, Lumeka Kabwende A . A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med. 2012; 367(24):2284-95. PMC: 10915853. DOI: 10.1056/NEJMoa1208394. View

2.
Neafsey D, Juraska M, Bedford T, Benkeser D, Valim C, Griggs A . Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. N Engl J Med. 2015; 373(21):2025-2037. PMC: 4762279. DOI: 10.1056/NEJMoa1505819. View

3.
Hernan M . The hazards of hazard ratios. Epidemiology. 2009; 21(1):13-5. PMC: 3653612. DOI: 10.1097/EDE.0b013e3181c1ea43. View

4.
Gilbert P, Self S, Ashby M . Statistical methods for assessing differential vaccine protection against human immunodeficiency virus types. Biometrics. 1998; 54(3):799-814. View

5.
Benkeser D, Carone M, B Gilbert P . Improved estimation of the cumulative incidence of rare outcomes. Stat Med. 2017; 37(2):280-293. PMC: 5735003. DOI: 10.1002/sim.7337. View